{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-24-002081","form_type":"8-K","ticker":"HSCS","cik":"0001468492","company_name":"HeartSciences Inc.","filed_at":"2024-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.140688+00:00","generated_at":"2026-05-31T15:41:28.034074+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"HeartSciences reports FY2024 cash of $5.8M; cloud-platform beta and FDA timeline updates","bullets":["Cash and equivalents $5.8M; shareholders' equity $7.3M as of April 30, 2024.","Net proceeds of $10.3M from stock sales; $1.1M debt converted to equity.","Issued common stock to Mount Sinai for algorithm licenses, recognizing $1.6M intangible asset.","MyoVista Insights cloud-platform beta completed; FDA submission targeted for mid-2025.","MyoVista wav ECG device FDA submission expected in Q1 2025 after final testing."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-24-002081","json":"https://secwatch.observer/filing/0001013762-24-002081.json","markdown":"https://secwatch.observer/filing/0001013762-24-002081.md","text":"https://secwatch.observer/filing/0001013762-24-002081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468492/000101376224002081/0001013762-24-002081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468492/000101376224002081/ea0210212-8k_heart.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:41:28.034074+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}